The TRAnsition for VALUE initiative was designed to highlight both the clinical and economic advantages of transradial PCI through a multi-faceted approach of didactic modules, webinars, in-person seminars, education toolkits and in-lab training that are targeted to all cath lab key stakeholders to ensure the value of the transradial approach is fully realized across the care pathway.
The TRAnsition for VALUE education curriculum will be guided by the SCAI Quality Improvement Committee and supports SCAI’s consensus statement on transradial best practices.
Meet the Team
The TRAnsition for VALUE team of clinical professionals is committed to meeting the training and education needs of physicians, staff and administrators to build an efficient transradial practice and improve patient experiences.
Adhir Shroff, MD, FSCAI is an Associate Professor of Medicine at the University of Illinois – Chicago. He is Director of the Cardiac Catheterization Lab and the Interventional Cardiology Fellowship program. He has been involved with transradial angiography and intervention for the past 8 years. His clinical and research interests involve PCI quality and health care economics. He has developed and conducted numerous CME-approved educational programs for physicians, cath lab staff and administrators on topics such as transradial cardiac catheterization, intermediate lesion assessment, hemodynamic support devices and coronary atherectomy. He is chair of SCAI’s Vascular Access Working Group that advocates for improved access techniques and outcomes.
Sunil V. Rao, MD, FSCAI is a Professor of Medicine at Duke University Medical Center and the Chief of Cardiology at The Durham Veterans Affairs Medical Center. His main research interests deal with phase 2 clinical trials exploring the pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. He has led several clinical trials in the interventional cardiology space and his research has been published in leading medical journals including the American Heart Journal, the Journal of the American College of Cardiology, and JAMA. He is also the incoming Editor-in-Chief for Circulation Cardiovascular Interventions.
Q: Why is SCAI leading the TRAnsition for VALUE initiative?
A: Guided by the SCAI Quality Improvement Committee and supported by SCAI’s consensus statement on transradial best practices, the TRAnsition for VALUE initiative aligns with SCAI’s short- and long-term goals surrounding how the society approaches bundled payments and actively identifies and engages cath labs for process improvement. Although the transradial approach has been shown to effectively address two key components of value-based care: improving outcomes and lowering costs, SCAI believes that insufficient education and lack of training are the primary obstacles to more widespread adoption of this approach in the United States.
Q: Who is sponsoring the TRAnsition for VALUE initiative?
A: SCAI originally created this initiative with the assistance of founding sponsor Medtronic. Medtronic has been joined by Terumo and CSI in supporting this program to empower U.S. cardiologists, hospital administrators and cath lab staff with the necessary skills they need to increase the utilization of transradial PCI in the United States.
Q: What is the goal of the initiative?
A: As the U.S. healthcare system moves toward a value-based approach, TRAnsition for VALUE highlights the clinical and economic advantages of transradial interventions through robust educational programs. Ultimately, the goal of TRAnsition for VALUE is to develop Transradial Champions in cath labs across the country-defined as a physician or healthcare professional who takes a leading role with their peers and at their institution to ensure the value of the transradial procedures is fully realized for the benefit of their patients and institution.
Through the development of Transradial Champions, SCAI, Medtronic, Terumo and CSI hope to create a robust transradial community that can further share the patient benefits and cost effectiveness of the approach as well as help implement successful strategies to identify and overcome barriers to starting and optimizing a transradial program.
Q: Why does the initiative only focus on the transradial approach?
A: While the transfemoral approach to PCI is often successful, it is commonly associated with certain challenges, including an increased risk of bleeding complications at the insertion site and sometimes a slower recovery process for the patient compared to other approaches.
Due to the growing amount of evidence supporting the transradial approach, adoption in the United States has increased from 1.32 percent to nearly 30 percent over the past approximately fifteen years. While utilization is on the rise, the TRAnsition for VALUE initiative aims to accelerate adoption by overcoming insufficient education and lack of training in the United States that may present as obstacles to more widespread use.
Q: What are the procedural and economic benefits of the transradial approach?
A: While not all patients can benefit from the transradial approach, eligible patients may experience:
- Improved safety with reductions in major bleeding and vascular complications
- Reduced risk of mortality
- Improved comfort and quality of life
- Shortened length of hospital stay
Please send your questions and comments to SCAI at firstname.lastname@example.org